Weight loss drugs linked with growing number of side effects
The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are reporting. In very rare cases they can be deadly. Here’s what to know.
I can’t go to work & am scared to move from the loo because of Mounjaro… but people say it’s down to WHERE I’m injecting
A MOUNJARO user has claimed that after 19 weeks of injecting, she is “too scared to move away from the toilet” as a result of her side effects. Maddy, who has lost 40lbs [2 stone 8lbs] since using the weight loss jabs, is now unable to go to work as a result of suffering from […]
Viking Therapeutics: What’s Next After GLP-1 Hype Dies Down And Competition Intensifies
The golden dose of Mounjaro that helps you shift the MOST weight – and why it’s OK to still be hungry on the jab
EXPERTS have revealed the golden dose of Mounjaro that helps shift the most weight – and it’s not the highest one. Weight loss jab users tend to start on lower doses and gradually increase them as their body adjusts, to a maximum of 15mg. GettyAs little as 7.5mg of Mounjaro can lead to effective weight […]
I’ve lost 5 stone on Mounjaro but have a ‘painful’, ‘burning’ side effect no one talks about – it’s driving me crazy
A WOMAN who dropped five stone using Mounjaro has warned other users of a ‘painful’ side effect that’s making her life hell. Ann, who shares her weight loss journey on TikTok, opened up about her lesser-known struggle after taking the popular jab for 40 weeks. A tiktoker has shared her rarely discussed Mounjaro side-effect Ann […]
Glucagon‐like peptide‐1 is involved in fasting and postprandial blood flow regulation of subcutaneous adipose tissue
Abstract Aims Glucagon-like peptide 1 (GLP-1) is a gastrointestinal hormone with pleiotropic functions, including vasodilatory and vasculoprotective effects. As GLP-1 increases after a meal, it could be involved in adipose tissue blood flow (ATBF) regulation. In one-third of healthy people, the postprandial ATBF response to meals is blunted. Whether this responder/non-responder phenomenon stems from an […]
Opinion: STAT+: How to evaluate GLP-1s and Medicare costs? Here’s one idea
Today, more than 40% of adults over 60 are considered obese, fueling chronic disease and straining Medicare’s budget. With the price tag for obesity-related care rising, some experts suggest covering GLP-1 medications for weight loss through Medicare could save billions, citing data that estimates Medicare spending could drop by $1,262 to $5,442 annually per beneficiary […]
Svelteness in China is a US$150 billion market, with dozens of drug producers vying for it
Vials of Eli Lilly’s Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, are seen in a fridge at a health clinic in Hyderabad, India, April 14, 2025. Photo: Reuters Sales of weight-loss drugs in the West have soared in recent years, driven by the approval of a new class […]
🧪Decoding GLP-1 Scams: A Consumer’s Guide
This post is to make alerts consumers to various deceptive practices surrounding GLP-1 medications, which are often used for weight loss and diabetes management. It highlights risks associated with unregulated compounded injections from online clinics, stressing that only FDA-approved drugs from licensed pharmacies are proven safe. The guide also exposes false claims made by oral supplements, sprays, […]
Ozempic and Other GLP-1 Side Effects May Outweigh the Benefits
Learn how the benefits of GLP-1s may be outweighed by the risks.